Amryt Pharma plc reaffirmed revenue guidance for fiscal year 2022. For the year, the company is reaffirming revenue guidance for fiscal year 2022 in the range of $260 million - $270 million which represents growth of 17% to 21% on fiscal year 2021.
1st Jan change | Capi. | |
---|---|---|
+8.15% | 101B | |
+8.29% | 42.63B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B | |
-55.52% | 8.98B |